Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 49: 1039-1040, 2003; 10.1373/49.7.1039
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwertner, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwertner, H. A.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2003;49:1039-1040.)
© 2003 American Association for Clinical Chemistry, Inc.

Editorial

Bilirubin Concentration, UGT1A1*28 Polymorphism, and Coronary Artery Disease

Harvey A. Schwertner1

1 Clinical Research, Wilford Hall Medical Center, Lackland AFB, TX 78236, Fax 210-292-6053, E-mail schwertner@lackland.af.mil

The first 20% of the full text of this article appears below.

An inverse association between serum bilirubin and cardiovascular disease has been shown in numerous retrospective and prospective studies (1)(2)(3)(4)(5)(6)(7)(8) as well as in a metaanalysis study (9). Schwertner et al. (1) first reported that fasting serum bilirubin concentrations are inversely related to coronary artery stenosis in men. Low serum bilirubin concentrations were found to be associated with an increased risk of coronary artery disease (CAD), whereas bilirubin concentrations near the upper end of the reference interval were associated with a low risk of CAD. The strength of the association between bilirubin and CAD was similar to that of smoking, systolic blood pressure, and HDL-cholesterol.

Hopkins et al. (2) confirmed the findings in a retrospective case-controlled study of men and women with early familial CAD. Individuals in the top quintile of serum bilirubin concentrations had an 80% reduction in CAD risk compared with individuals in the lowest quintile. Low bilirubin concentrations also have been found in individuals with peripheral vascular disease (PVD) (3) and ischemic heart disease (IHD) (6)(7)(8).

Several prospective studies have shown that low serum bilirubin predicts future cardiovascular disease. In 1995, Breimer et al. (6) performed a prospective study of 7685 middle-aged men enrolled in the British Regional Heart Study (BRHS) and found that both low and high bilirubin concentrations were associated with an increased risk of CAD. In a prospective study of serum bilirubin and myocardial infarction (MI) in the Framingham Offspring Study (7. . . [Full Text of this Article]


Protective Effect of Increased Bilirubin Concentrations




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
C.-S. Ki, K.-A Lee, S.-Y. Lee, H.-J. Kim, S. S. Cho, J.-H. Park, S. Cho, K. M. Sohn, and J.-W. Kim
Haplotype Structure of the UDP-Glucuronosyltransferase 1A1 (UGT1A1) Gene and Its Relationship to Serum Total Bilirubin Concentration in a Male Korean Population
Clin. Chem., December 1, 2003; 49(12): 2078 - 2081.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.